Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Evidence-based Treatment Improves Survival in Patients With Invasive Breast Cancer

NCT04798976 is registered in ClinicalTrials.gov with Center of Personalized Medicine, Pirogova as lead sponsor.

NCT NCT04798976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Evidence-based Treatment Improves Survival in Patients With Invasive Breast Cancer
Lead sponsor
Center of Personalized Medicine, Pirogova
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2021
Completion date
May 30, 2021
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer-specific survival